Viking Therapeutics (VKTX) Misses Q4 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Viking Therapeutics (VKTX) Misses Q4 EPS by 12c

Viking Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results and Provides Corporate Update

March 8, 2016 4:05 PM EST

SAN DIEGO, March 8, 2016 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced financial results for the fourth quarter and year-end  2015, and provided an update on its clinical pipeline and other corporate developments.

Highlights from, and Subsequent to, the Year Ended December 31, 2015

"2015 was a successful and productive year for Viking," said Brian Lian, Ph.D., president and chief executive officer of Viking.  "In the last twelve months, we completed... More